Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: United Kingdom Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20081
20097
20111
20126
20137
20144
20154
20161
20172
20182
20193
20213
20221
20233
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting12
Recruiting9
Terminated8
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Hoffmann-La Roche6
BeOne Medicines5
Acerta Pharma BV4
Loxo Oncology, Inc.4
Pharmacyclics LLC.4
AbbVie3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
BeiGene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell60
Lymphoma, Non-Hodgkin12
Lymphoma, Follicular10
Lymphoma, B-Cell, Marginal Zone9
Leukemia8
Lymphoma8
Waldenstrom Macroglobulinemia7
Burkitt Lymphoma6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Mantle-Cell6

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.